{
"info": {
"nct_id": "NCT06662760",
"official_title": "A Phase I Clinical Study of TQB3002 in Patients With Advanced Cancers",
"inclusion_criteria": "* Subjects voluntarily joined this study, signed the informed consent form, and had good compliance;\n* Age: 18-75 years; Eastern Cooperative Oncology Group (ECOG) score: 0-1 ; Expected survival of more than 3 months;\n* Histologically or cytologically diagnosed with advanced cancers\n* Subjects with advanced malignancies who have failed standard therapy or lack effective treatment\n* Major organs are functioning well;\n* Female and male subjects of childbearing potential should agree to practice contraception for the duration of the study and for 6 months after the end of the study.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Current concomitant presence of other malignancies within 5 years prior to the first dose;\n* Unresolved toxicity above CTCAE Grade 1 due to any prior anti-tumor therapy\n* Significant surgical treatment, biopsy, or significant traumatic injury within 4 weeks prior to the first dose\n* Long-term unhealed wounds or fractures\n* Cerebrovascular accident (including transient ischemic attack, intracerebral hemorrhage, cerebral infarction), deep vein thrombosis, and pulmonary embolism within 6 months prior to the first dose\n* Swallowing dysfunction, active gastrointestinal diseases or other diseases that significantly affect the absorption, distribution, metabolism and excretion of the study drug, or previous subtotal gastrectomy\n* A history of psychotropic drug abuse and cannot be abstained from or have a mental disorder\n* Subjects with any severe and/or uncontrolled disease",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Subjects voluntarily joined this study, signed the informed consent form, and had good compliance;",
"criterions": [
{
"exact_snippets": "Subjects voluntarily joined this study",
"criterion": "voluntary participation",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"exact_snippets": "signed the informed consent form",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
},
{
"exact_snippets": "had good compliance",
"criterion": "compliance",
"requirements": [
{
"requirement_type": "quality",
"expected_value": "good"
}
]
}
]
},
{
"line": "* Age: 18-75 years; Eastern Cooperative Oncology Group (ECOG) score: 0-1 ; Expected survival of more than 3 months;",
"criterions": [
{
"exact_snippets": "Age: 18-75 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 75,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) score: 0-1",
"criterion": "ECOG score",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "Expected survival of more than 3 months",
"criterion": "expected survival",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Histologically or cytologically diagnosed with advanced cancers",
"criterions": [
{
"exact_snippets": "Histologically or cytologically diagnosed with advanced cancers",
"criterion": "cancer diagnosis",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologically",
"cytologically"
]
},
{
"requirement_type": "stage",
"expected_value": "advanced"
}
]
}
]
},
{
"line": "* Subjects with advanced malignancies who have failed standard therapy or lack effective treatment",
"criterions": [
{
"exact_snippets": "advanced malignancies",
"criterion": "malignancy stage",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "advanced"
}
]
},
{
"exact_snippets": "failed standard therapy",
"criterion": "standard therapy outcome",
"requirements": [
{
"requirement_type": "outcome",
"expected_value": "failed"
}
]
},
{
"exact_snippets": "lack effective treatment",
"criterion": "availability of effective treatment",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* Major organs are functioning well;",
"criterions": [
{
"exact_snippets": "Major organs are functioning well",
"criterion": "major organ function",
"requirements": [
{
"requirement_type": "functionality",
"expected_value": "well"
}
]
}
]
},
{
"line": "* Female and male subjects of childbearing potential should agree to practice contraception for the duration of the study and for 6 months after the end of the study.",
"criterions": [
{
"exact_snippets": "Female and male subjects of childbearing potential",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "should agree to practice contraception for the duration of the study and for 6 months after the end of the study",
"criterion": "contraception agreement",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "for the duration of the study and for 6 months after the end of the study"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Current concomitant presence of other malignancies within 5 years prior to the first dose;",
"criterions": [
{
"exact_snippets": "Current concomitant presence of other malignancies",
"criterion": "other malignancies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "within 5 years prior to the first dose",
"criterion": "time since other malignancies",
"requirements": [
{
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Unresolved toxicity above CTCAE Grade 1 due to any prior anti-tumor therapy",
"criterions": [
{
"exact_snippets": "Unresolved toxicity above CTCAE Grade 1 due to any prior anti-tumor therapy",
"criterion": "toxicity",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "CTCAE Grade"
}
}
]
}
]
},
{
"line": "* Significant surgical treatment, biopsy, or significant traumatic injury within 4 weeks prior to the first dose",
"criterions": [
{
"exact_snippets": "Significant surgical treatment",
"criterion": "surgical treatment",
"requirements": [
{
"requirement_type": "time since occurrence",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "biopsy",
"criterion": "biopsy",
"requirements": [
{
"requirement_type": "time since occurrence",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "significant traumatic injury",
"criterion": "traumatic injury",
"requirements": [
{
"requirement_type": "time since occurrence",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Long-term unhealed wounds or fractures",
"criterions": [
{
"exact_snippets": "Long-term unhealed wounds",
"criterion": "wounds",
"requirements": [
{
"requirement_type": "healing status",
"expected_value": "unhealed"
},
{
"requirement_type": "duration",
"expected_value": "long-term"
}
]
},
{
"exact_snippets": "Long-term unhealed ... fractures",
"criterion": "fractures",
"requirements": [
{
"requirement_type": "healing status",
"expected_value": "unhealed"
},
{
"requirement_type": "duration",
"expected_value": "long-term"
}
]
}
]
},
{
"line": "* Cerebrovascular accident (including transient ischemic attack, intracerebral hemorrhage, cerebral infarction), deep vein thrombosis, and pulmonary embolism within 6 months prior to the first dose",
"criterions": [
{
"exact_snippets": "Cerebrovascular accident (including transient ischemic attack, intracerebral hemorrhage, cerebral infarction) ... within 6 months prior to the first dose",
"criterion": "cerebrovascular accident",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "deep vein thrombosis ... within 6 months prior to the first dose",
"criterion": "deep vein thrombosis",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "pulmonary embolism within 6 months prior to the first dose",
"criterion": "pulmonary embolism",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Swallowing dysfunction, active gastrointestinal diseases or other diseases that significantly affect the absorption, distribution, metabolism and excretion of the study drug, or previous subtotal gastrectomy",
"criterions": [
{
"exact_snippets": "Swallowing dysfunction",
"criterion": "swallowing dysfunction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "active gastrointestinal diseases",
"criterion": "active gastrointestinal diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other diseases that significantly affect the absorption, distribution, metabolism and excretion of the study drug",
"criterion": "diseases affecting drug absorption, distribution, metabolism, and excretion",
"requirements": [
{
"requirement_type": "impact",
"expected_value": "significant"
}
]
},
{
"exact_snippets": "previous subtotal gastrectomy",
"criterion": "previous subtotal gastrectomy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* A history of psychotropic drug abuse and cannot be abstained from or have a mental disorder",
"criterions": [
{
"exact_snippets": "A history of psychotropic drug abuse",
"criterion": "psychotropic drug abuse",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "cannot be abstained from",
"criterion": "psychotropic drug abstinence",
"requirements": [
{
"requirement_type": "ability to abstain",
"expected_value": false
}
]
},
{
"exact_snippets": "have a mental disorder",
"criterion": "mental disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Subjects with any severe and/or uncontrolled disease",
"criterions": [
{
"exact_snippets": "any severe and/or uncontrolled disease",
"criterion": "disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}